Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2021.08.019
Brazilian Journal of Anesthesiology
Original Investigation

The effect of two different doses of dexmedetomidine to prevent emergence agitation in children undergoing adenotonsillectomy:a randomized controlled trial

O efeito de duas doses diferentes de dexmedetomidina para prevenir a agitação ao despertar em crianças submetidas à adenotonsilectomia: um ensaio clínico randomizado  

Wenjing Yi, Jie Li, Yan Zhuang, Lichun Wan, Wenxian Li, Jie Jia

Downloads: 0
Views: 187

Abstract

Objective
To evaluate different doses of dexmedetomidine for the prevention of emergence agitation in children undergoing adenotonsillectomy.

Method
130 children aged 3-10 years scheduled for adenotonsillectomy were randomly assigned to two groups. Anesthesia was induced with 0.5 μg.kg-1 dexmedetomidine (DEX 0.5 group) or 1 μg.kg-1 dexmedetomidine (DEX 1 group) at the beginning of surgery. Observers who recorded the data in the post-anesthesia care unit were blinded to the allocation. The primary outcome was the percentage of emergence agitation. The times to spontaneous breath, awake, extubate, and post anesthesia care unit stay were also recorded.

Results
124 children were randomized into two groups. 5 children were excluded because of adverse events and dropout (DEX 0.5 group, n = 58; DEX 1 group, n = 62). No significant differences were noted in the percentage of emergence agitation between the two groups. The times to extubation(p = 0.003), awake and post-anesthesia care unit stay in DEX 0.5 group were shorter than those in DEX 1 group (p <  0.0001). There was no significant difference between the two groups in the time to spontaneous breath. Approximately 8% of patients in DEX 0.5 group and 18% patients in DEX 1 group presented low SpO2, showing a significant difference between the two groups (p = 0.043).

Conclusions
0.5 μg.kg-1 dexmedetomidine was equally effective as 1 μg.kg-1 dexmedetomidine in preventing emergence agitation.

Trial registration
: The trial is currently completed recruitment, registered in ClinicalTrials.gov (ID:NCT03760809). Inclusion began on 4 January, 2019.

Keywords

Dexmedetomidine;  Emergence agitation

Resumo

Objetivo: Avaliar diferentes doses de dexmedetomidina na prevenção da agitação ao despertar em crianças submetidas à adenotonsilectomia.

Método: Cento e trinta crianças de 3 a 10 anos agendadas para adenotonsilectomia foram divididas aleatoriamente em dois grupos. A anestesia foi induzida com 0,5 μg.kg-1 de dexmedetomidina(Grupo DEX 0,5) ou 1 μg.kg-1 de dexmedetomidina (grupo DEX 1) no início da cirurgia. Os observadores que registraram os dados na unidade de recuperação pós-anestésica desconheciam a alocação. O desfecho primário foi a porcentagem de agitação ao despertar. Os tempos de respiração espontânea, despertar, extubar e permanência na unidade de recuperação pós-anestésica também foram registrados.

Resultados: Cento e vinte e quatro crianças foram randomizados em dois grupos. Cinco crianças foram excluídas devido a eventos adversos e abandono (grupo DEX 0,5, n = 58; grupo DEX 1, n = 62). Não foram observadas diferenças significativas na porcentagem de agitação ao despertar entre os dois grupos. Os tempos de extubação (p = 0,003), vigília e permanência na unidade de recuperação pós-anestésica no grupo DEX 0,5 foram menores do que no grupo DEX 1 (p <0,0001). Não houve diferença significante entre os dois grupos no tempo até a respiração espontânea. Aproximadamente 8% dos pacientes do grupo DEX 0,5 e 18% dos pacientes do grupo DEX 1 apresentaram SpO2 baixa, mostrando diferença significativa entre os dois grupos (p = 0,043).

Conclusões: Uma dose de 0,5 g.kg-1 de dexmedetomidina foi tão eficaz quanto 1 μg.kg-1 de dexmedetomidina na prevenção da agitação ao despertar.

Palavras-chave

Dexmedetomidina, Agitação de emergência  

References

1. Wells LT, Rasch DK. Emergence “delirium” after sevoflurane anesthesia: a paranoid delusion? Anesth Analge. 1999;88(6):1308-10.

2. Terri VL, Shobha M, Tait AR. A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit. Anesth Analg. 2003;96(6):1625.

3. Eckenhoff J, Kneale D, Dripps R. The incidence and etiology of postanesthetic excitement. Anesthesiology. 1961;22:667-73.

4. Uezono S, Goto T, Terui K, et al. Emergence agitation after sevoflurane versus propofol in pediatric patients. Anesth Analg. 2000;91(3):563-66.

5. Olutoyin O, Tae K, Carla G, et al. Dexmedetomidine as an analgesic for pediatric tonsillectomy and adenoidectomy. Paediatr Anaesth. 2010;17(10):1007-08.

6. Gulen G, Aynur A, Zeynep T, et al. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Paediatr Anaesth.
2010;15(9):762-66.

7. Erdil F, Demirbilek S, Begec Z, et al. The Effects of Dexmedetomidine and Fentanyl on Emergence Characteristics after Adenoidectomy in Children. Anaesth Intensive Care.
2009;37(4):571-76.

8. Bedirli N, Akcabay M, Emik U. Tramadol vs dexmedetomidine for emergence agitation control in pediatric patients undergoing adenotonsillectomy with sevoflurane anesthesia:
prospective randomized controlled clinical study. BMC Anesthesiol. 2017;17(1):41.

9. Anuradha P, Melissa D, Tran MCJ, et al. Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy. Anesth Analg. 2010;111(4):1004-10.

10. Xing-Ying H, Jian-Ping C, Xue-Yin S, et al. Dexmedetomidine versus morphine or fentanyl in the management of children after tonsillectomy and adenoidectomy: a meta-analysis of randomized controlled trials. Ann Otol Rhinol Laryngol. 2013;122(2):114-20.

11. Lerman J. Development and Psychometric Evaluation of the Pediatric Anesthesia Emergence Delirium Scale. Anesthesiology. 2004;100(5):1138.

12. JW C, DJ M, JD M, et al. Emergence behaviour in children: defining the incidence of excitement and agitation following anaesthesia. Paediatr Anaesth. 2002;12(5):442-47.

13. CH Y. Development and validation of the Asian version of the oucher: a pain intensity scale for children. J Pain. 2005;6(8):526-34.

14. Dahmani S, Stany I, Brasher C, et al. Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies.
Br J Anaesth. 2010;104(2):216-23.

15. Jiao H, Wang H, Jiang Z, et al. Comparative efficacy of ancillary drugs in sevoflurane-related emergence agitation after paediatric adenotonsillectomy: A Bayesian network meta-analysis. J Clin Pharm Thera. 2020.

16. Sato M, Shirakami G, Tazuke-Nishimura M, et al. Effect of single-dose dexmedetomidine on emergence agitation and recovery profiles after sevoflurane anesthesia in pediatric
ambulatory surgery. J Anesth. 2010;24(5):675-82.

17. Ibacache ME, Muñoz HR, Verena B, et al. Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg. 2004;98(1):60-63.

18. Shukry M, Clyde MCKalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Pediatr Anesth. 2010;15(12):1098-04.

19. Di M, Han Y, Yang Z, et al. Tracheal extubation in deeply anesthetized pediatric patients after tonsillectomy: a comparison of high-concentration sevoflurane alone and low-concentration sevoflurane in combination with dexmedetomidine pre-medication. BMC anesthesiol. 2017;17(1):28.

20. Petroz G, Sikich N, M, Van-Dyk H, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology.
2006;105(6):1098-10.

21. Cao JL, Pei YP, Wei JQ, et al. Effects of intraoperative dexmedetomidine with intravenous anesthesia on postoperative emergence agitation/delirium in pediatric patients
undergoing tonsillectomy with or without adenoidectomy: A CONSORT-prospective, randomized, controlled clinical trial. Medicine (Baltimore). 2016;95(49): e5566.

22. Carolyn R. Aradine, Beyer JE, Tompkins JM. Children’s pain perception before and after analgesia: A study of instrument construct validity and related issues. J Pediatr
Nurs.1988;3(1):11-23.

23. Beyer JE, CR A. Content validity of an instrument to measure young children’s perceptions of the intensity of their pain. J Pediatr Nurs. 1986;1(6):386-95.

24. Lootens CC, Rapof MA. Measures of pediatric pain: 21–Numbered Circle Visual Analog Scale (VAS), E‐Ouch Electronic Pain Diary, Oucher, Pain Behavior Observation Method, Pediatric Pain Assessment Tool (PPAT), and Pediatric Pain Questionnaire (PPQ). Arthritis Care Res (Hoboken). 2011;63(S11): S253-62. 

25. Ripamonti CI, Santini D, Maranzano E, et al. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7(suppl_6): vii139.

26. Sang HL, Lee CJ, Kim TH, et al. Novel Use of Hydromorphone as a Pretreatment Agent: A Double-blind, Randomized, Controlled Study in Adult Korean Surgical Patients. Curr Ther Res Clin Exp. 2011;72(1):36-48.

27. Felden L, Walter C, Harder S, et al. Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth. 2011;107(3):319-28.

28. Ye J, Liu H, Zhang G, Huang Z, et, al. Postoperative respiratory complications of adenotonsillectomy for obstructive sleep apnea syndrome in older children: prevalence, risk
factors, and impact on clinical outcome. J Otolaryngol Head Neck Surg 2009;38:49-58.

29. Kou YF, Sakai M, Shah GB, et al. Postoperative respiratory complications and racial disparities following inpatient pediatric tonsillectomy: A cross-sectional study. The Laryngoscope. 2018;00:1-6.


Submitted date:
11/16/2019

Accepted date:
08/07/2021

617ae080a953954ab6405627 rba Articles

Braz J Anesthesiol

Share this page
Page Sections